View Archive

Medical Crossfire®: A New Dawn of T-Cell Engaging Immunotherapy: Improving Outcomes for Patients With Acute Lymphoblastic Leukemia

Medical Crossfire®: A New Dawn of T-Cell Engaging Immunotherapy: Improving Outcomes for Patients With Acute Lymphoblastic Leukemia

25 September 2019

Crowne Plaza Rome – St. Peter’s
Via Aurelia Antica, 415
00165 Roma RM, Italy
Phone: +39 06 66420


This live Medical Crossfire® will feature a series of short presentations of the latest data covering advances in treatment for acute lymphoblastic leukemia (ALL), followed by case presentations and expert panel discussions to place emerging treatment options into context. The emergence of T-cell engaging therapies to treat lymphomas and leukemias have created new opportunities in the treatment of relapsed/refractory ALL or ALL in remission with measurable residual disease (MRD). Bispecific T-cell engagers can redirect T-cells to exert cytotoxic activity against tumor cells, and have demonstrated efficacy in B-ALL. However, identifying in which patients and at which point in therapy these new agents should be used can be challenging, given rapidly emerging data and advances in strategies to monitor response to lines of therapy, such as MRD. In this engaging discussion-based symposium, key experts in the field of ALL treatment will challenge each other to apply the latest data to specific patient scenarios, and provide their perspective on how to apply MRD information to guide treatment planning, including the use of T-cell engaging therapies.

Accreditation/Credit Designation

Physicians' Education Resource®, LLC is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

Physicians' Education Resource®, LLC, designates this live activity for a maximum of 1.5 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Acknowledgment of Commercial Support

This activity is supported by an educational grant from Amgen Inc.

Target Audience:

This educational activity is intended for international hematologists, medical oncologists, and other healthcare professionals interested in the latest advances in the treatment of patients with ALL. Fellows, researchers, nurses, nurse practitioners, physician assistants, and other healthcare professionals interested in the treatment of patients with ALL are also invited to participate.

Learning Objectives

Upon successful completion of this activity, you should be better prepared to:

  • Describe the biology of ALL in terms of biomarkers, testing strategies, and methods to stratify risk for patients with this hematologic malignancy.
  • Differentiate the role of T-cell engaging immunotherapy in MRD status in treatment decisions for patients with ALL.
  • Incorporate key findings from recent clinical trials concerning the use of T-cell engaging immunotherapy treatment strategies for patients with ALL in the frontline and relapsed/refractory settings into practice.
  • Discuss the recent evidence and clinical trials involving T-cell immunotherapies in other hematological malignancies.

Benefits of Attending

  • Gain an understanding of the latest data regarding the use of T-cell engaging therapies in the treatment of ALL.
  • Hear expert perspective on how and when to apply the latest advances in treatment for ALL.
  • Engage with leading experts in the treatment of ALL to challenge your treatment decision making in light of emerging options and novel data.

Program Chair

Elias Jabbour
Elias Jabbour, MD
Department of Leukemia
The University of Texas MD Anderson Cancer Center
Houston, TX


25 September 2019

Crowne Plaza Rome – St. Peter’s
Via Aurelia Antica, 415
00165 Roma RM, Italy
Phone: +39 06 66420

Registration fees include reception and e-syllabus materials.

2 Ways to Register:

  1. Online: Click here.
  2. Phone: Please call +1-(888)-949-0045 or +1-(609)-378-3701.

Physicians' Education Resource®, LLC – PEG-19-SS00381
2 Clarke Drive
Suite 110
Cranbury, NJ 08512

  Advance On-Site
Physicians $0 $0
Fellows* $0 $0
Nurses, PAs, Other Health Care Professionals $0 $0
Industry** $0 $0

*FELLOWS registration must be accompanied by a letter from your director/chair stating current fellowship for discount. Cannot be combined with other discounts/coupon codes.
**INDUSTRY is defined by Physicians' Education Resource®, LLC (PER®) as any person employed by a for-profit organization, including biotech, financial, and pharmaceutical.

For registration assistance, please email, or call +1-(888)-949-0045 or +1-(609)-378-3701.

PER® fully complies with the legal requirements of the Americans with Disabilities Act (ADA) and the rules and regulations thereof. If any participant in this educational activity is in need of accommodations, please notify us in order to receive service. Please call +1-(609)-378-3701.

PER® reserves the exclusive rights to all recordings or reproductions of the conference and supporting materials. Unauthorized recording, by any means, is expressly prohibited. This includes, but is not limited to, recording of presentations or reproductions of supporting audio/visual materials, exhibits, and other supporting Continuing Education materials.

By attending a PER® conference, meeting, or related activity ("Events"), all participants, attendees, exhibitors, sponsors, and guests ("you") create an agreement between you and PER® regarding the use and distribution of your image, including but not limited to your name, voice, and likeness ("Image"). By attending the Events, you acknowledge and agree that photographs, video, and/or audio recordings may be taken of you and you grant permission to PER® (and its agents) to utilize, in perpetuity, your Image in any electronic or print distribution, or by other means hereinafter created, both now and in the future, for any lawful purpose as determined by PER®.

Meeting information is accurate at the time of posting.

PER® complies with the Physician Payments Sunshine Act as part of the Affordable Care Act. Accordingly, we may be required to collect information on transfers of value provided to any covered recipient under the Act.


You must be logged in to PER to register for this meeting

Or Register for PER now

*Required Fields

Login Information

Registration Information

In case of onsite emergency:

Professional Information


Calendar of Events
Filter By